Table 2 Base case product characteristics. Simulated characteristics in parentheses
Product | HIV efficacy (bounds used in uncertainty analysis – uniform distribution) | STI efficacy | Contraceptive protection | Frequency of use |
|---|---|---|---|---|
Oral pre-exposure prophylaxis | 61% (40–75%) | N (Y) | N (Y) | Daily |
Vaginal Ring | 55% (31–71%) | N (Y) | N (Y) | Monthly |
Injectable ARVs | 75% (55–90%) | N (Y) | N (Y) | Every three months |
Condom | 85% (66–94%) | Y | Y | Coital |
No condom | 0 | N | N | Coital |